BOLD BlogNews and views from Cavidi

Keep in touch

Join our mailing list to receive new information relating to biomarker discovery and detection.

Exazym®: New Detection Limits Open New Possibilities

Exazym® — Pixels to Proteins

Exazym® — Ultra-Sensitivity Meets Practicality

Exazym® — A Breakthrough in Precision Health

Cavidi supports Diagnostics Access Initiative

Cavidi strongly supports the Diagnostics Access Initiative (DAI)...

Continue reading

Cavidi in Swedish TECH20 - top 2% of start ups

The TECH20 winners have been announced - the 20 most c...

Continue reading

Investment with Impact: Closing the HIV treatment gap

I was pleased to speak at the United Nations this week as part o...

Continue reading

Cavidi Selected to Present at Cavendish Global Health Impact Forum

Stockholm 11th April 2014 — Cavidi, a specialis...

Continue reading

World Aids Day 2013: Halfway to Zero

Each year World Aids Day helps raise awareness around the world....

Continue reading

Cavidi and Burnet Institute sign CD4 license agreement

Leading Swedish HIV diagnostic company Cavidi today an...

Continue reading

Cavidi joins UIC Business Accelerator

Cavidi, leading Swedish HIV companion diagnostic supplier, joins...

Continue reading

Viral load monitoring enters the mainstream

Last night I attended a dinner in Stockholm hosted by the Swedis...

Continue reading
Close Menu
×
×

Cart